[The effect comparison of ranibizumab and sodium pegaptanib on the retinal pigment epithelium ablation size in the treatment of age-related macular degeneration].

@article{n2012TheEC,
  title={[The effect comparison of ranibizumab and sodium pegaptanib on the retinal pigment epithelium ablation size in the treatment of age-related macular degeneration].},
  author={M {\vS}{\'i}n and M Jakubcov{\'a} and Oldrich Chrapek and Zuzana Prachařov{\'a} and J Simic{\'a}k and Jiř{\'i} Řeh{\'a}k},
  journal={Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti},
  year={2012},
  volume={68 2},
  pages={57-60}
}
AIM To evaluate the effect difference of ranibizumab and sodium pegaptanib in the ablation treatment of the retinal pigment epithelium (RPE) in age-related macular degeneration MATERIAL AND METHODS Retrospective analysis of data of patients with age-related macular degeneration treated by means of anti-VEGF therapy at the Department of Ophthalmology… CONTINUE READING